慢性肝病
医学
人口
肝病
肝硬化
疾病
肝功能检查
脂肪肝
内科学
酒精性肝病
环境卫生
出处
期刊:PubMed
[National Institutes of Health]
日期:2021-09-20
卷期号:29 (9): 825-829
标识
DOI:10.3760/cma.j.cn501113-20210826-00430
摘要
Due to its insidious nature, chronic liver disease usually only appears after a decompensating event, and delays in diagnosis lead to a high mortality. Non-invasive examination can help diagnose and intervene early stage liver fibrosis in patients with chronic liver disease. In a hospital population, this test has been widely used and appropriate; however, its value is unclear in the general community population. In recent years, there have been many studies on non-invasive examinations for foreign community populations. These non-invasive examination tools can screen patients with chronic liver disease and liver cirrhosis among the general community population. Further studies have found that screening community populations with liver disease risk factors (heavy alcohol consumption, type 2 diabetes mellitus, and obesity) can more efficiently screen out patients with chronic liver disease in the community population. In brief, these noninvasive examination can find a large number of previously undiscovered liver disease patients in the community population, compared to traditional community screening that rely on abnormal liver function testing. This paper discusses the non-invasive examination in the screening of chronic liver disease among the community population, so as to find a pioneering community non-invasive liver disease screening path for our country.
科研通智能强力驱动
Strongly Powered by AbleSci AI